COVID-19 and lung cancer: a comprehensive overview from outbreak to recovery
M Bungaro, F Passiglia, GV Scagliotti - Biomedicines, 2022 - mdpi.com
Lung cancer patients have been associated with an increased risk of COVID-19 infection,
pulmonary complications, and worse survival outcomes compared to the general population …
pulmonary complications, and worse survival outcomes compared to the general population …
Omicron related COVID-19 prevention and treatment measures for patients with hematological malignancy and strategies for modifying hematologic treatment regimes
W Guo, Y Zheng, S Feng - Frontiers in Cellular and Infection …, 2023 - frontiersin.org
The Omicron variant of SARS-CoV-2 has rapidly become the dominant strain worldwide due
to its high transmissibility, although it appears to be less pathogenic than previous strains …
to its high transmissibility, although it appears to be less pathogenic than previous strains …
Impact of the COVID-19 pandemic on treatment patterns for patients with metastatic solid cancer in the United States
Background The COVID-19 pandemic has led to delays in patients seeking care for life-
threatening conditions; however, its impact on treatment patterns for patients with metastatic …
threatening conditions; however, its impact on treatment patterns for patients with metastatic …
Concerns related to the interactions between COVID-19 vaccination and cancer/cancer treatment were barriers to complete primary vaccination series among …
L Zhang, J Yang, R Su, X Du, Y Wang… - Human Vaccines & …, 2023 - Taylor & Francis
ABSTRACT COVID-19 vaccination is effective for cancer patients without safety concerns.
However, COVID-19 vaccination hesitancy is common among cancer patients. This study …
However, COVID-19 vaccination hesitancy is common among cancer patients. This study …
[HTML][HTML] Impact of coronavirus disease 2019 on lung cancer patients: A meta-analysis
L Wang, Y Wang, X Cheng, X Li, J Li - Translational Oncology, 2023 - Elsevier
Background The coronavirus disease 2019 (COVID-19) pandemic poses a great challenge
to the treatment of lung cancer patients. Materials and methods The PubMed, Embase, and …
to the treatment of lung cancer patients. Materials and methods The PubMed, Embase, and …
Systemic anticancer therapy and thromboembolic outcomes in hospitalized patients with cancer and COVID-19
Importance Systematic data on the association between anticancer therapies and
thromboembolic events (TEEs) in patients with COVID-19 are lacking. Objective To assess …
thromboembolic events (TEEs) in patients with COVID-19 are lacking. Objective To assess …
Patient perspectives on chemotherapy de‐escalation in breast cancer
GB Rocque, CP Williams, C Andrews… - Cancer …, 2021 - Wiley Online Library
Background Given excellent survival outcomes in breast cancer, there is interest in de‐
escalating the amount of chemotherapy delivered to patients. This approach may be of even …
escalating the amount of chemotherapy delivered to patients. This approach may be of even …
Infectious diseases as a cause of death among cancer patients: a trend analysis and population-based study of outcome in the United States based on the …
Background Infectious diseases are a major cause of morbidity and mortality among cancer
patients. We aimed to determine the incidence of infectious diseases as a cause of death …
patients. We aimed to determine the incidence of infectious diseases as a cause of death …
Leveraging Black pharmacists to promote equity in COVID‐19 vaccine uptake within Black communities: a framework for researchers and clinicians
JC Abdul‐Mutakabbir, B Simiyu… - Journal of the …, 2022 - Wiley Online Library
Black Americans are disproportionately represented among coronavirus disease 2019
(COVID‐19)‐related morbidities and mortalities. While the COVID‐19 vaccines are …
(COVID‐19)‐related morbidities and mortalities. While the COVID‐19 vaccines are …
SARS-CoV-2 neutralizing antibodies kinetics postvaccination in cancer patients under treatment with immune checkpoint inhibition
Simple Summary Solid tumor patients under active anticancer treatment are peculiarly
affected by COVID-19 infection, given not only its ominous outcomes but also the need of …
affected by COVID-19 infection, given not only its ominous outcomes but also the need of …